Department of Anesthesiology and Pain Medicine, University of California, Davis, Sacramento, California 95819, USA.
Pain Med. 2013 Jun;14(6):792-8. doi: 10.1111/pme.12062. Epub 2013 Mar 5.
To review confidentiality requirements of prescribers who become aware of a forged prescription.
A case is reviewed in which a prescriber believes that a prescription has been forged.
The literature and law related to prescription forgery and confidentiality are reviewed. Although prescription forgery is a crime, the prescriber's responsibility for reporting to law enforcement is not clear under current state and federal law. Federal laws and regulations, including the Health Insurance Portability and Accountability Act (HIPAA), do not permit prescribers in all circumstances to disclose prescription fraud to law enforcement.
Under common circumstances, HIPAA may prohibit prescribers from reporting prescription forgery to law enforcement. However, collaborating with a dispensing pharmacist may offer a lawful pathway to reporting prescription forgery. State legislature may consider laws that clarify the reporting responsibilities of prescribers in cases of prescription forgery.
审查发现伪造处方的处方医师的保密要求。
审查了这样一种情况,即一名处方医师认为处方是伪造的。
审查了与处方伪造和保密性相关的文献和法律。尽管处方伪造是一种犯罪,但根据现行的州和联邦法律,处方医师向执法部门报告的责任并不明确。包括《健康保险携带和责任法案》(HIPAA)在内的联邦法律和法规不允许处方医师在所有情况下向执法部门披露处方欺诈行为。
在常见情况下,HIPAA 可能会禁止处方医师向执法部门报告处方伪造行为。然而,与配药药剂师合作可能提供了报告处方伪造行为的合法途径。州立法机构可能会考虑制定法律,明确处方医师在处方伪造案件中的报告责任。